2-(Piperazin-1-yl)-1-(piperidin-1-yl)ethanone

Catalog No. :
ACLZGM940
CAS No. :
70558-13-3
Molecular Formula :
C11H21N3O
Molecular Weight :
211.31

IUPAC Name:2-(piperazin-1-yl)-1-(piperidin-1-yl)ethan-1-one

2-(Piperazin-1-yl)-1-(piperidin-1-yl)ethanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$132.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Piperazin-1-yl)-1-(piperidin-1-yl)ethanone
IUPAC Name2-(piperazin-1-yl)-1-(piperidin-1-yl)ethan-1-one
MDL No.MFCD01075233
Molecular FormulaC11H21N3O
Molecular Weight211.31
SMILESO=C(N1CCCCC1)CN2CCNCC2
InChI KeyPCHXUJGLAFXWIW-UHFFFAOYSA-N
Synonym1-(2-oxo-2-piperidin-1-ylethyl)piperazine(SALTDATA: FREE);1-[2-Oxo-2-(piperidin-1-yl)ethyl]piperazine, 1-[(Piperazin-1-yl)acetyl]piperidine;2-(Piperazin-1-yl)-1-(piperidin-1-yl)ethan-1-one 97%;2-(1-piperazinyl)-1-(1-piperidyl)ethanone;2-piperazin-1-yl-1-(1-piperidyl)ethanone;2-piperazin-1-yl-1-piperidino-ethanone;ST5342213;2-(Piperazin-1-yl)-1-(piperidin-1-yl)ethan-1-one97%
CAS No.70558-13-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P305+P351+P338-P337+P313-P501

Synthetic Route by SureRoute

1. ACLZGM940 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACLZGM940 route product structure diagram
    ACLZGM94070558-13-3
Inquiry

2. ACLZGM940 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLZGM940 route product structure diagram
    ACLZGM94070558-13-3
Inquiry

Comments (0)